Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Ilomastat successful in treating exposure to mustard gas

April 24, 2003

Elite develops opioid antagonist product to minimize abuse potential

April 17, 2003

TA-CD enters phase IIa cocaine administration study

April 16, 2003

Evidence for potential of SB-277011-A in drug dependence and psychosis

April 11, 2003

HE-2100 protects nonhuman primates from effects of radiation exposure

April 9, 2003

Enrollment complete in phase III trial of Vivitrex in alcohol dependence

April 3, 2003

Large Scale Biology and U. of Arkansas enter agreement for drug intervention therapy

March 5, 2003

5-HT1A agonists with utility in the treatment of opioid dependence

March 5, 2003

Potential use of selegiline hydrochloride in promoting smoking cessation

March 4, 2003

NicVAX phase I/II trial begins enrollment

Feb. 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...